GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Study Identifies Disrupted Theta Oscillations in Basolateral Amygdala and Ventral Hippocampus Linked to Social Stress

by GOAI
Share To

A recent study published in *BMC Neuroscience* has identified changes in theta oscillations within specific brain regions as a result of social stress. Researchers, led by X. Wang and Y. Liu, observed alterations in the basolateral amygdala and ventral hippocampus, two areas of the brain associated with emotional processing and memory. The findings provide new insights into how social defeat—a form of chronic stress—affects neural activity.

The study focused on examining theta oscillations, which are rhythmic patterns of brain activity linked to cognitive and emotional processes. Researchers found that exposure to social defeat caused significant disruptions in these oscillations within the basolateral amygdala and ventral hippocampus. These results highlight potential neural mechanisms underlying the effects of social stress on mental health. While the broader implications remain under investigation, this research contributes to a growing body of work exploring the relationship between stress and brain function.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top